GEN Exclusives

More »

GEN Poll

More »
Oct 31, 2013

Clinical Genomics

Scientists recently reported that the use of next-generation sequencing may help improve the treatment strategies for advanced cancer patients with progressing tumors. The study highlighted some challenges that could be holding clinical genomics back. What do you think is the biggest obstacle?

What is the main obstacle holding back clinical genomics?

Cost of sequencing
 
  9.4%
Sequencing’s inherent limitations
 
  14.1%
Reporting delays/information custody issues
 
  9.4%
Complexity of sharing and understanding data
 
  67.1%

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »